Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate STAAR Surgical Co before investing.

In this article, we go over a few key elements for understanding STAAR Surgical Co’s stock price such as:

• STAAR Surgical Co’s current stock price and volume
• Why STAAR Surgical Co’s stock price changed recently
• Upgrades and downgrades for STAA from analysts
• STAA’s stock price momentum as measured by its relative strength

About STAAR Surgical Co (STAA)

Before we jump into STAAR Surgical Co’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.

Want to learn more about STAAR Surgical Co’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about STAAR Surgical Co.

STAAR Surgical Co’s Stock Price as of Market Close

As of July 02, 2024, 4:00 PM, CST, STAAR Surgical Co’s stock price was $44.52.

STAAR Surgical Co is down 6.12% from its previous closing price of $47.42.

During the last market session, STAAR Surgical Co’s stock traded between $46.85 and $48.40. Currently, there are 48.91 million shares of STAAR Surgical Co stock available for purchase.

STAAR Surgical Co’s price-earnings (P/E) ratio is currently at 153.3, which is high compared to the Medical Equipment, Supplies & Distribution industry median of 38.5. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

STAAR Surgical Co Stock Price History

STAAR Surgical Co’s (STAA) price is currently down 6.49% so far this month.

During the month of July, STAAR Surgical Co’s stock price has reached a high of $49.32 and a low of $42.99.

Over the last year, STAAR Surgical Co has hit prices as high as $58.82 and as low as $26.66. Year to date, STAAR Surgical Co’s stock is down 8.28%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused STAAR Surgical Co Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 01, 2024, there were 3 analysts who downgraded STAAR Surgical Co’s stock and 4 analysts who upgraded over the last month.

Additionally, you'll want to evaluate STAAR Surgical Co’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on STAAR Surgical Co’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

STAAR Surgical Co’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about STAAR Surgical Co (STAA) by visiting AAII Stock Evaluator.

Relative Price Strength of STAAR Surgical Co

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 01, 2024, STAAR Surgical Co has a weighted four-quarter relative price strength of -1.35%, which translates to a Momentum Score of 68 and is considered to be Strong.

Want to learn more about how STAAR Surgical Co is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

STAAR Surgical Co Stock Price: Bottom Line

As of July 2, 2024, STAAR Surgical Co’s stock price is $44.52, which is down 6.12% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like STAAR Surgical Co stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.